News

APOLLO ENDOSURGERY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apollo Endosurgery, Inc. - APEN

NEW ORLEANS--( BUSINESS WIRE )--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Apollo Endosurgery, Inc. (NasdaqGM: APEN) to Boston Scientific Corporation (NYSE: BSX). Under the terms of the proposed transaction, shareholders of Apollo will receive only $10.00 in cash for each share of Apollo that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

11/29/2022

SHAREHOLDER ALERT: Weiss Law Investigates Apollo Endosurgery, Inc.

NEW YORK , Nov. 29, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Apollo Endosurgery, Inc. ("Apollo Endosurgery" or the "Company") (NASDAQ: APEN), in connection with the proposed acquisition of the Company by Boston Scientific Corporation (NYSE: BSX). Under the terms of the merger agreement, the Company's shareholders will receive $10.00 in cash for each share of Apollo Endosurgery common stock owned.

11/29/2022

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Apollo Endosurgery, Inc. (APEN) a buy, sell, or hold?

Apollo Endosurgery, Inc. (APEN) can hold. Click on Rating Page for detail.

What is Apollo Endosurgery, Inc.'s stock price?

The price of Apollo Endosurgery, Inc. (APEN) is 10 and it was updated on 2024-07-27 07:02:18.

Is Apollo Endosurgery, Inc. (APEN) overvalued or undervalued?

Currently Apollo Endosurgery, Inc. (APEN) is in undervalued.

News

From:

To:

News
Buy-rated Boston Scientific's $615 million takeover of Apollo Endosurgery is a positive, says Needham Boston Scientific Corp.'s BSX, +0.88% $615 million acquisition of Apollo Endosurgery Inc. APEN, +65.50% announced earlier is complementary to the former's endoscopy franchise, as it leverages its gastroenterologist call point while offering the potential for it to expand into surgical endoscopy and bariatric surgery, Needham analysts aid Tuesday. The deal is expected to have no material impact on Boston Scientific's 2023 per-share earnings but to boost it after that. Tue, Nov. 29, 2022
Apollo Endosurgery Stock Soars on Buyout Buzz Apollo Endosurgery Inc (NASDAQ:APEN) stock is soaring, up 63.4% at $9.80 at last glance, after news that Boston Scientific Corp (BSX) will acquire the medical equipment name for $417 million. Tue, Nov. 29, 2022
Boston Scientific to acquire Apollo Endosurgery for $615 million in cash Boston Scientific Corp. BSX, -0.82% said Tuesday it has agreed to acquire Apollo Endosurgery Inc. APEN, for $10 a share, or about $615 million in cash. The news sent Apollo's stock, which closed Monday at $6, up 61% in premarket trade. Tue, Nov. 29, 2022
Apollo Endosurgery to be Acquired by Boston Scientific Boston Scientific to acquire Apollo for $10.00 per share in cash AUSTIN, TX / ACCESSWIRE / November 29, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a leading minimally invasive medical device company for gastrointestinal and bariatric procedures, announced today it has entered into a definitive merger agreement to be acquired by Boston Scientific Corporation ("Boston Scientific"), a global medical technology leader, in an all-cash transaction with an enterprise value of approximately $615 million.[1] This transaction has been unanimously approved by the Apollo Board of Directors. Tue, Nov. 29, 2022
Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc. Acquisition to expand endoluminal surgery portfolio and add differentiated technologies for endobariatric procedures MARLBOROUGH, Mass. , Nov. 29, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Apollo Endosurgery, Inc. (Nasdaq: APEN) for a cash price of $10 per share, reflecting an enterprise value of approximately $615 million.1 The Apollo Endosurgery product portfolio includes devices used during endoluminal surgery (ELS) procedures to close gastrointestinal defects, manage gastrointestinal complications and aid in weight loss for patients suffering from obesity. Tue, Nov. 29, 2022

Transcripts

Transcipts Data
Apollo Endosurgery, Inc. (APEN) on Q3 2022 Results - Earnings Call Transcript SA Transcripts Tue, Nov. 01, 2022
Apollo Endosurgery, Inc. (APEN) on Q2 2022 Results - Earnings Call Transcript SA Transcripts Mon, Aug. 08, 2022
Apollo Endosurgery, Inc. (APEN) on Q1 2022 Results - Earnings Call Transcript SA Transcripts Tue, May. 03, 2022
Apollo Endosurgery, Inc. (APEN) on Q4 2021 Results - Earnings Call Transcript SA Transcripts Tue, Feb. 22, 2022
Apollo Endosurgery, Inc. (APEN) on Q3 2021 Results - Earnings Call Transcript SA Transcripts Mon, Nov. 01, 2021
Apollo Endosurgery, Inc. (APEN) on Q2 2021 Results - Earnings Call Transcript SA Transcripts Tue, Aug. 03, 2021
Apollo Endosurgery, Inc. (APEN) on Q1 2021 Results - Earnings Call Transcript SA Transcripts Tue, May. 04, 2021

SEC Filings

SEC Filings
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 05/08/2023
Apollo Endosurgery, Inc. (APEN) - 15-12G SEC Filings 04/14/2023
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 04/10/2023
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 04/10/2023
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 04/10/2023
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 04/10/2023
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 04/10/2023
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 04/10/2023
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 04/10/2023
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 04/10/2023
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 04/05/2023
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 04/04/2023
Apollo Endosurgery, Inc. (APEN) - S-8 POS SEC Filings 04/04/2023
Apollo Endosurgery, Inc. (APEN) - POS AM SEC Filings 04/04/2023
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 04/04/2023
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 04/04/2023
Apollo Endosurgery, Inc. (APEN) - 25-NSE SEC Filings 04/04/2023
Apollo Endosurgery, Inc. (APEN) - 10-K - Current report SEC Filings 03/30/2023
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/14/2023
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/13/2023
Apollo Endosurgery, Inc. (APEN) - DEFA14A SEC Filings 02/13/2023
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 02/10/2023
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 02/10/2023
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/08/2023
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/06/2023
Apollo Endosurgery, Inc. (APEN) - DEFA14A SEC Filings 02/01/2023
Apollo Endosurgery, Inc. (APEN) - DEFA14A SEC Filings 01/31/2023
Apollo Endosurgery, Inc. (APEN) - DEFM14A SEC Filings 01/10/2023
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 12/30/2022
Apollo Endosurgery, Inc. (APEN) - PREM14A SEC Filings 12/30/2022
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/30/2022
Apollo Endosurgery, Inc. (APEN) - DEFA14A SEC Filings 12/29/2022
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 12/29/2022
Apollo Endosurgery, Inc. (APEN) - DEFA14A SEC Filings 12/28/2022
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 12/28/2022
Apollo Endosurgery, Inc. (APEN) - DEFA14A SEC Filings 12/01/2022
Apollo Endosurgery, Inc. (APEN) - DEFA14A SEC Filings 11/30/2022
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 11/30/2022
Apollo Endosurgery, Inc. (APEN) - DEFA14A SEC Filings 11/29/2022
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 11/29/2022
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 11/04/2022
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 11/01/2022
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 11/01/2022
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 10/06/2022
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 08/05/2022
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 08/02/2022
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 08/02/2022
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/13/2022
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/06/2022
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 07/06/2022
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 06/16/2022
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 06/16/2022
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/14/2022
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 05/09/2022
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 05/03/2022
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 05/03/2022
Apollo Endosurgery, Inc. (APEN) - DEFA14A SEC Filings 04/25/2022
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 04/25/2022
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 04/04/2022
Apollo Endosurgery, Inc. (APEN) - 4/A SEC Filings 03/10/2022
Apollo Endosurgery, Inc. (APEN) - 3/A SEC Filings 03/10/2022
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 03/01/2022
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 03/01/2022
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 02/28/2022
Apollo Endosurgery, Inc. (APEN) - S-8 SEC Filings 02/23/2022
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 02/22/2022
Apollo Endosurgery, Inc. (APEN) - 10-K - Current report SEC Filings 02/22/2022
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/15/2022
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/14/2022
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/11/2022
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/10/2022
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/03/2022
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 01/10/2022
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 12/21/2021
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 12/20/2021
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 11/01/2021
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 11/01/2021
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 10/19/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 10/19/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 10/18/2021
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 10/14/2021
Apollo Endosurgery, Inc. (APEN) - 424B5 SEC Filings 10/13/2021
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 10/12/2021
Apollo Endosurgery, Inc. (APEN) - 424B5 SEC Filings 10/12/2021
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 10/07/2021
Apollo Endosurgery, Inc. (APEN) - 4/A SEC Filings 08/20/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 08/20/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 08/11/2021
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 08/06/2021
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 08/03/2021
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 08/03/2021
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/16/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 07/08/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 07/07/2021
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/24/2021
Apollo Endosurgery, Inc. (APEN) - 8-K/A - Current report SEC Filings 06/22/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 06/21/2021
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/17/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 06/15/2021
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 05/20/2021
Apollo Endosurgery, Inc. (APEN) - 4/A SEC Filings 05/20/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 05/20/2021
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 05/19/2021
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 05/17/2021
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 05/11/2021
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 05/07/2021
Apollo Endosurgery, Inc. (APEN) - S-3 SEC Filings 05/05/2021
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 05/04/2021
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 05/04/2021
Apollo Endosurgery, Inc. (APEN) - DEFA14A SEC Filings 05/03/2021
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 05/03/2021
Apollo Endosurgery, Inc. (APEN) - DEFA14A SEC Filings 04/27/2021
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 04/27/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 04/13/2021
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/25/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 03/12/2021
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 03/12/2021
Apollo Endosurgery, Inc. (APEN) - S-8 SEC Filings 03/10/2021
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 03/09/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 03/09/2021
Apollo Endosurgery, Inc. (APEN) - 8-K/A - Current report SEC Filings 03/03/2021
Apollo Endosurgery, Inc. (APEN) - S-8 SEC Filings 02/26/2021
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 02/25/2021
Apollo Endosurgery, Inc. (APEN) - 10-K - Current report SEC Filings 02/25/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 02/24/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 02/22/2021
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/16/2021
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/12/2021
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 02/08/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 02/08/2021
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/05/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 02/05/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 02/03/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 01/07/2021
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/17/2020
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 12/07/2020
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 11/05/2020
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 11/05/2020
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 10/13/2020
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 10/13/2020
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 10/09/2020
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 09/28/2020
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 09/10/2020
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 08/28/2020
Apollo Endosurgery, Inc. (APEN) - DEFA14A SEC Filings 08/26/2020
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 08/26/2020
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 08/25/2020
Apollo Endosurgery, Inc. (APEN) - 424B7 SEC Filings 08/25/2020
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 08/24/2020
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 08/20/2020
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 08/18/2020
Apollo Endosurgery, Inc. (APEN) - S-3 SEC Filings 08/13/2020
Apollo Endosurgery, Inc. (APEN) - PRE 14A SEC Filings 08/12/2020
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 08/04/2020
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 08/04/2020
Apollo Endosurgery, Inc. (APEN) - D SEC Filings 07/30/2020
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 07/22/2020
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/22/2020
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 07/21/2020
Apollo Endosurgery, Inc. (APEN) - DEFA14A SEC Filings 07/02/2020
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 07/02/2020
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/01/2020
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 06/18/2020
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 06/18/2020
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 06/17/2020
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 05/22/2020
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 05/11/2020
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 05/04/2020
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 05/04/2020
Apollo Endosurgery, Inc. (APEN) - S-8 SEC Filings 04/30/2020
Apollo Endosurgery, Inc. (APEN) - 10-K/A - Current report SEC Filings 04/29/2020
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 04/20/2020
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/26/2020
Apollo Endosurgery, Inc. (APEN) - 10-K - Current report SEC Filings 03/26/2020
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/05/2020
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/14/2020
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/13/2020
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 01/06/2020
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 11/12/2019
Apollo Endosurgery, Inc. (APEN) - 424B7 SEC Filings 11/12/2019
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 11/08/2019
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 11/06/2019
Apollo Endosurgery, Inc. (APEN) - S-3/A SEC Filings 10/31/2019
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 10/31/2019
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 10/30/2019
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 10/30/2019
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 09/12/2019
Apollo Endosurgery, Inc. (APEN) - D SEC Filings 08/27/2019
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 08/26/2019
Apollo Endosurgery, Inc. (APEN) - S-3 SEC Filings 08/23/2019
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 08/22/2019
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 08/20/2019
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 08/16/2019
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 08/15/2019
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 08/14/2019
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 08/14/2019
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 08/08/2019
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 07/24/2019
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/23/2019
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/27/2019
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/11/2019
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 05/14/2019
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 05/10/2019
Apollo Endosurgery, Inc. (APEN) - S-8 SEC Filings 05/03/2019
Apollo Endosurgery, Inc. (APEN) - 10-K/A - Current report SEC Filings 05/03/2019
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 05/02/2019
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 05/02/2019
Apollo Endosurgery, Inc. (APEN) - DEFA14A SEC Filings 04/24/2019
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 04/24/2019
Apollo Endosurgery, Inc. (APEN) - 8-K/A - Current report SEC Filings 04/16/2019
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 04/04/2019
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 03/28/2019
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/27/2019
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/18/2019
Apollo Endosurgery, Inc. (APEN) - 10-K - Current report SEC Filings 03/18/2019
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/05/2019
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/14/2019
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 02/14/2019
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 02/14/2019
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 01/18/2019
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 01/02/2019
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/31/2018
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/28/2018
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 12/21/2018
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 12/19/2018
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 11/21/2018
Apollo Endosurgery, Inc. (APEN) - 10-Q/A - Quarterly Report SEC Filings 11/13/2018
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 11/08/2018
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 11/08/2018
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 11/06/2018
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 08/15/2018
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 08/08/2018
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 08/08/2018
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 06/22/2018
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/21/2018
Apollo Endosurgery, Inc. (APEN) - 424B5 SEC Filings 06/21/2018
Apollo Endosurgery, Inc. (APEN) - 424B5 SEC Filings 06/19/2018
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/15/2018
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 05/30/2018
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 05/30/2018
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 05/03/2018
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 05/03/2018
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 04/16/2018
Apollo Endosurgery, Inc. (APEN) - DEFA14A SEC Filings 04/06/2018
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 04/06/2018
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/13/2018
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 03/13/2018
Apollo Endosurgery, Inc. (APEN) - S-8 SEC Filings 03/06/2018
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 03/02/2018
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/01/2018
Apollo Endosurgery, Inc. (APEN) - 10-K - Current report SEC Filings 03/01/2018
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 02/23/2018
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/13/2018
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/08/2018
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 01/03/2018
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/28/2017
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/22/2017
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 12/21/2017
Apollo Endosurgery, Inc. (APEN) - 424B5 SEC Filings 12/20/2017
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 12/19/2017
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 12/18/2017
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 12/13/2017
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/13/2017
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/11/2017
Apollo Endosurgery, Inc. (APEN) - S-3 SEC Filings 12/04/2017
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 12/01/2017
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 11/30/2017
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 11/17/2017
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 11/17/2017
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 11/09/2017
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 11/01/2017
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 10/26/2017
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 10/26/2017
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 09/25/2017
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 09/25/2017
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 09/19/2017
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 08/25/2017
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 08/18/2017
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 08/18/2017
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 08/16/2017
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 08/14/2017
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 08/01/2017
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 08/01/2017
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 07/31/2017
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 07/27/2017
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 07/26/2017
Apollo Endosurgery, Inc. (APEN) - 424B4 SEC Filings 07/21/2017
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 07/20/2017
Apollo Endosurgery, Inc. (APEN) - S-1MEF SEC Filings 07/19/2017
Apollo Endosurgery, Inc. (APEN) - S-1/A SEC Filings 07/18/2017
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 07/17/2017
Apollo Endosurgery, Inc. (APEN) - S-1/A SEC Filings 07/12/2017
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 07/12/2017
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/12/2017
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 06/28/2017
Apollo Endosurgery, Inc. (APEN) - S-8 SEC Filings 06/15/2017
Apollo Endosurgery, Inc. (APEN) - S-1 SEC Filings 06/14/2017
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/13/2017
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/01/2017
Apollo Endosurgery, Inc. (APEN) - 4/A SEC Filings 05/30/2017
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 05/30/2017
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 05/18/2017
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 05/11/2017
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 05/04/2017
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 05/04/2017
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 04/28/2017
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 04/12/2017
Apollo Endosurgery, Inc. (APEN) - PRE 14A SEC Filings 04/11/2017
Apollo Endosurgery, Inc. (APEN) - 10-K - Current report SEC Filings 03/24/2017
Apollo Endosurgery, Inc. (APEN) - 8-K/A - Current report SEC Filings 03/10/2017
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/08/2017
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 03/03/2017
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 02/17/2017
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 02/17/2017
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/14/2017
Apollo Endosurgery, Inc. (APEN) - S-8 SEC Filings 01/31/2017
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 01/26/2017
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 01/20/2017
Apollo Endosurgery, Inc. (APEN) - SC 13D SEC Filings 01/10/2017
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 01/09/2017
Apollo Endosurgery, Inc. (APEN) - SC 13D SEC Filings 01/09/2017
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 01/06/2017
Apollo Endosurgery, Inc. (APEN) - SC 13D SEC Filings 01/04/2017
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 01/04/2017
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 01/03/2017
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/30/2016
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/29/2016
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 12/29/2016
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 12/28/2016
Apollo Endosurgery, Inc. (APEN) - 425 SEC Filings 12/19/2016
Apollo Endosurgery, Inc. (APEN) - 425 SEC Filings 12/15/2016
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 12/02/2016
Apollo Endosurgery, Inc. (APEN) - CT ORDER SEC Filings 12/01/2016
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 12/01/2016
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 11/29/2016
Apollo Endosurgery, Inc. (APEN) - S-4/A SEC Filings 11/23/2016
Apollo Endosurgery, Inc. (APEN) - S-4/A SEC Filings 11/14/2016
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 11/14/2016
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 11/10/2016
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 11/08/2016
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 10/18/2016
Apollo Endosurgery, Inc. (APEN) - 425 SEC Filings 10/18/2016
Apollo Endosurgery, Inc. (APEN) - S-4 SEC Filings 10/11/2016
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 09/13/2016
Apollo Endosurgery, Inc. (APEN) - 425 SEC Filings 09/13/2016
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 09/08/2016
Apollo Endosurgery, Inc. (APEN) - 425 SEC Filings 09/08/2016
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 09/07/2016
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 09/01/2016
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 09/01/2016
Apollo Endosurgery, Inc. (APEN) - S-3 SEC Filings 08/22/2016
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 08/09/2016
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/18/2016
Apollo Endosurgery, Inc. (APEN) - 424B5 SEC Filings 06/24/2016
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/09/2016
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 05/10/2016
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 04/28/2016
Apollo Endosurgery, Inc. (APEN) - PRE 14A SEC Filings 04/15/2016
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 04/13/2016
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 04/08/2016
Apollo Endosurgery, Inc. (APEN) - POS AM SEC Filings 04/06/2016
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 04/01/2016
Apollo Endosurgery, Inc. (APEN) - POS AM SEC Filings 03/25/2016
Apollo Endosurgery, Inc. (APEN) - 10-K - Current report SEC Filings 03/22/2016
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 03/16/2016
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 02/18/2016
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 01/12/2016
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 01/06/2016
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 11/12/2015
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 09/29/2015
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 09/10/2015
Apollo Endosurgery, Inc. (APEN) - S-8 SEC Filings 08/11/2015
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 08/11/2015
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/14/2015
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/18/2015
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 06/18/2015
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 05/20/2015
Apollo Endosurgery, Inc. (APEN) - 424B5 SEC Filings 05/08/2015
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 05/08/2015
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 04/27/2015
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 04/23/2015
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 04/13/2015
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 04/10/2015
Apollo Endosurgery, Inc. (APEN) - POS AM SEC Filings 03/24/2015
Apollo Endosurgery, Inc. (APEN) - 10-K - Current report SEC Filings 03/24/2015
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/23/2015
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 02/12/2015
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 02/11/2015
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 01/16/2015
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 01/09/2015
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/12/2014
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 12/02/2014
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 11/12/2014
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 11/04/2014
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 11/04/2014
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 11/04/2014
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 10/24/2014
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 10/23/2014
Apollo Endosurgery, Inc. (APEN) - S-3 SEC Filings 10/14/2014
Apollo Endosurgery, Inc. (APEN) - D SEC Filings 10/07/2014
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 10/03/2014
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 10/02/2014
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 09/23/2014
Apollo Endosurgery, Inc. (APEN) - 424B5 SEC Filings 09/23/2014
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 09/22/2014
Apollo Endosurgery, Inc. (APEN) - 424B5 SEC Filings 09/22/2014
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 08/21/2014
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 08/19/2014
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 08/18/2014
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 08/08/2014
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/24/2014
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/21/2014
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/01/2014
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 06/20/2014
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/02/2014
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 05/09/2014
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 05/09/2014
Apollo Endosurgery, Inc. (APEN) - PRE 14A SEC Filings 04/24/2014
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 04/03/2014
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 04/02/2014
Apollo Endosurgery, Inc. (APEN) - POS AM SEC Filings 03/24/2014
Apollo Endosurgery, Inc. (APEN) - 424B5 SEC Filings 03/18/2014
Apollo Endosurgery, Inc. (APEN) - 10-K - Current report SEC Filings 03/18/2014
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 02/14/2014
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 02/12/2014
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 02/11/2014
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 02/10/2014
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 11/08/2013
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 10/11/2013
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 10/08/2013
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 08/26/2013
Apollo Endosurgery, Inc. (APEN) - S-3 SEC Filings 08/15/2013
Apollo Endosurgery, Inc. (APEN) - S-8 SEC Filings 08/14/2013
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 08/14/2013
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/03/2013
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 06/27/2013
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/21/2013
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 05/08/2013
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 05/07/2013
Apollo Endosurgery, Inc. (APEN) - DEFR14A SEC Filings 05/01/2013
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 04/26/2013
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 04/26/2013
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 04/25/2013
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 04/23/2013
Apollo Endosurgery, Inc. (APEN) - CT ORDER SEC Filings 04/22/2013
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 04/22/2013
Apollo Endosurgery, Inc. (APEN) - PRE 14A SEC Filings 04/12/2013
Apollo Endosurgery, Inc. (APEN) - POS AM SEC Filings 04/12/2013
Apollo Endosurgery, Inc. (APEN) - 10-K - Current report SEC Filings 03/15/2013
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/08/2013
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 02/07/2013
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 01/31/2013
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/20/2012
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/19/2012
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 12/14/2012
Apollo Endosurgery, Inc. (APEN) - 424B5 SEC Filings 12/14/2012
Apollo Endosurgery, Inc. (APEN) - 424B5 SEC Filings 12/13/2012
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 12/11/2012
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 11/21/2012
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 11/16/2012
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 11/09/2012
Apollo Endosurgery, Inc. (APEN) - S-3 SEC Filings 11/02/2012
Apollo Endosurgery, Inc. (APEN) - 8-A12B/A SEC Filings 10/31/2012
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 10/29/2012
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 10/26/2012
Apollo Endosurgery, Inc. (APEN) - CERTNAS SEC Filings 10/19/2012
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 10/18/2012
Apollo Endosurgery, Inc. (APEN) - 8-A12B SEC Filings 10/18/2012
Apollo Endosurgery, Inc. (APEN) - 8-K/A - Current report SEC Filings 10/05/2012
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 10/04/2012
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 08/13/2012
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 08/10/2012
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 08/01/2012
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 08/01/2012
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 08/01/2012
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/22/2012
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/05/2012
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 05/14/2012
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 05/10/2012
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 05/10/2012
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 05/10/2012
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 05/09/2012
Apollo Endosurgery, Inc. (APEN) - POS AM SEC Filings 04/30/2012
Apollo Endosurgery, Inc. (APEN) - POS AM SEC Filings 04/27/2012
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 04/27/2012
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 03/27/2012
Apollo Endosurgery, Inc. (APEN) - 10-K - Current report SEC Filings 03/16/2012
Apollo Endosurgery, Inc. (APEN) - 424B4 SEC Filings 03/07/2012
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/06/2012
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 02/15/2012
Apollo Endosurgery, Inc. (APEN) - S-1/A SEC Filings 02/14/2012
Apollo Endosurgery, Inc. (APEN) - S-1/A SEC Filings 02/10/2012
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 02/10/2012
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 02/09/2012
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/07/2012
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 02/01/2012
Apollo Endosurgery, Inc. (APEN) - 5 SEC Filings 01/31/2012
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 01/30/2012
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 01/27/2012
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 01/24/2012
Apollo Endosurgery, Inc. (APEN) - S-1/A SEC Filings 12/23/2011
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 12/14/2011
Apollo Endosurgery, Inc. (APEN) - S-1 SEC Filings 12/07/2011
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 11/14/2011
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 10/26/2011
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 08/12/2011
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/24/2011
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/03/2011
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 05/11/2011
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 05/09/2011
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 05/09/2011
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 05/09/2011
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 05/06/2011
Apollo Endosurgery, Inc. (APEN) - CT ORDER SEC Filings 05/04/2011
Apollo Endosurgery, Inc. (APEN) - POS AM SEC Filings 04/22/2011
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 04/20/2011
Apollo Endosurgery, Inc. (APEN) - 10-K - Current report SEC Filings 03/23/2011
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 03/11/2011
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/14/2011
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 02/14/2011
Apollo Endosurgery, Inc. (APEN) - 5 SEC Filings 02/08/2011
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 01/14/2011
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 01/11/2011
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 01/05/2011
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 01/05/2011
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 12/27/2010
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 12/23/2010
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 12/21/2010
Apollo Endosurgery, Inc. (APEN) - S-1/A SEC Filings 12/21/2010
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/21/2010
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 12/20/2010
Apollo Endosurgery, Inc. (APEN) - S-1 SEC Filings 12/07/2010
Apollo Endosurgery, Inc. (APEN) - D SEC Filings 12/01/2010
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 11/18/2010
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 11/09/2010
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 09/30/2010
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 09/03/2010
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 09/03/2010
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 08/12/2010
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/30/2010
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/06/2010
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 06/01/2010
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 06/01/2010
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 06/01/2010
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 05/28/2010
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 05/26/2010
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 05/26/2010
Apollo Endosurgery, Inc. (APEN) - POS AM SEC Filings 05/21/2010
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 05/13/2010
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 05/12/2010
Apollo Endosurgery, Inc. (APEN) - POS AM SEC Filings 05/07/2010
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 04/29/2010
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 04/23/2010
Apollo Endosurgery, Inc. (APEN) - PRE 14A SEC Filings 04/21/2010
Apollo Endosurgery, Inc. (APEN) - 10-K - Current report SEC Filings 03/29/2010
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 02/17/2010
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 02/10/2010
Apollo Endosurgery, Inc. (APEN) - CT ORDER SEC Filings 01/22/2010
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 01/19/2010
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 11/12/2009
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 09/24/2009
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 08/24/2009
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 08/12/2009
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 07/16/2009
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 07/13/2009
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 07/07/2009
Apollo Endosurgery, Inc. (APEN) - 8-K/A - Current report SEC Filings 07/07/2009
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/02/2009
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 06/05/2009
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 05/29/2009
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 05/15/2009
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 05/14/2009
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 05/14/2009
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 05/13/2009
Apollo Endosurgery, Inc. (APEN) - POS AM SEC Filings 05/01/2009
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 04/27/2009
Apollo Endosurgery, Inc. (APEN) - CT ORDER SEC Filings 04/17/2009
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 04/01/2009
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 03/30/2009
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 03/27/2009
Apollo Endosurgery, Inc. (APEN) - 10-K - Current report SEC Filings 03/25/2009
Apollo Endosurgery, Inc. (APEN) - 8-K/A - Current report SEC Filings 03/13/2009
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/12/2009
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/13/2009
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 02/11/2009
Apollo Endosurgery, Inc. (APEN) - 5 SEC Filings 02/10/2009
Apollo Endosurgery, Inc. (APEN) - 4/A SEC Filings 02/10/2009
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 11/18/2008
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 11/18/2008
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 11/14/2008
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 11/13/2008
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 11/03/2008
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 10/31/2008
Apollo Endosurgery, Inc. (APEN) - SC 13D SEC Filings 10/17/2008
Apollo Endosurgery, Inc. (APEN) - REGDEX SEC Filings 10/03/2008
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 10/02/2008
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 09/30/2008
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 09/29/2008
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 09/26/2008
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 09/26/2008
Apollo Endosurgery, Inc. (APEN) - S-1/A SEC Filings 09/25/2008
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 09/25/2008
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 09/24/2008
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 09/24/2008
Apollo Endosurgery, Inc. (APEN) - S-1/A SEC Filings 09/19/2008
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 09/17/2008
Apollo Endosurgery, Inc. (APEN) - S-1 SEC Filings 09/11/2008
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 08/20/2008
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 08/18/2008
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 08/18/2008
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 08/15/2008
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 08/14/2008
Apollo Endosurgery, Inc. (APEN) - 4/A SEC Filings 05/16/2008
Apollo Endosurgery, Inc. (APEN) - 10-Q - Quarterly Report SEC Filings 05/12/2008
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 05/09/2008
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 05/08/2008
Apollo Endosurgery, Inc. (APEN) - POS AM SEC Filings 04/28/2008
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 04/28/2008
Apollo Endosurgery, Inc. (APEN) - 5/A SEC Filings 03/28/2008
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 03/28/2008
Apollo Endosurgery, Inc. (APEN) - S-8 SEC Filings 03/20/2008
Apollo Endosurgery, Inc. (APEN) - 10KSB SEC Filings 03/20/2008
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/25/2008
Apollo Endosurgery, Inc. (APEN) - 5 SEC Filings 02/14/2008
Apollo Endosurgery, Inc. (APEN) - SC 13G/A SEC Filings 02/13/2008
Apollo Endosurgery, Inc. (APEN) - SC 13D SEC Filings 12/14/2007
Apollo Endosurgery, Inc. (APEN) - 4/A SEC Filings 12/14/2007
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 11/26/2007
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 11/23/2007
Apollo Endosurgery, Inc. (APEN) - 10QSB SEC Filings 11/13/2007
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 08/28/2007
Apollo Endosurgery, Inc. (APEN) - 10QSB SEC Filings 08/13/2007
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 07/27/2007
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 07/27/2007
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 07/12/2007
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 07/12/2007
Apollo Endosurgery, Inc. (APEN) - SB-2 SEC Filings 06/29/2007
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 06/19/2007
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 06/15/2007
Apollo Endosurgery, Inc. (APEN) - SC 13D/A SEC Filings 06/14/2007
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 06/14/2007
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 06/05/2007
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 05/31/2007
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 05/23/2007
Apollo Endosurgery, Inc. (APEN) - EFFECT SEC Filings 05/18/2007
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 05/18/2007
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 05/16/2007
Apollo Endosurgery, Inc. (APEN) - 10QSB SEC Filings 05/14/2007
Apollo Endosurgery, Inc. (APEN) - POS AM SEC Filings 05/07/2007
Apollo Endosurgery, Inc. (APEN) - REGDEX/A SEC Filings 04/27/2007
Apollo Endosurgery, Inc. (APEN) - PRE 14A SEC Filings 04/24/2007
Apollo Endosurgery, Inc. (APEN) - SC 13D SEC Filings 04/16/2007
Apollo Endosurgery, Inc. (APEN) - 10KSB SEC Filings 04/16/2007
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 04/10/2007
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 04/10/2007
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 04/10/2007
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 04/06/2007
Apollo Endosurgery, Inc. (APEN) - NT 10-K - Current report SEC Filings 03/30/2007
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/28/2007
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/27/2007
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/14/2007
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 01/29/2007
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 01/19/2007
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/18/2006
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 12/18/2006
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 12/06/2006
Apollo Endosurgery, Inc. (APEN) - 10QSB SEC Filings 11/13/2006
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 09/25/2006
Apollo Endosurgery, Inc. (APEN) - S-8 SEC Filings 09/14/2006
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 09/12/2006
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 09/08/2006
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 09/05/2006
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 08/22/2006
Apollo Endosurgery, Inc. (APEN) - 10QSB SEC Filings 08/11/2006
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 08/07/2006
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 08/07/2006
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/31/2006
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 07/27/2006
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/03/2006
Apollo Endosurgery, Inc. (APEN) - DEFR14A SEC Filings 05/22/2006
Apollo Endosurgery, Inc. (APEN) - 10QSB SEC Filings 05/12/2006
Apollo Endosurgery, Inc. (APEN) - DEF 14A SEC Filings 04/28/2006
Apollo Endosurgery, Inc. (APEN) - 424B3 SEC Filings 04/21/2006
Apollo Endosurgery, Inc. (APEN) - SB-2 SEC Filings 03/30/2006
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/29/2006
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 03/16/2006
Apollo Endosurgery, Inc. (APEN) - 10KSB SEC Filings 03/16/2006
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/08/2006
Apollo Endosurgery, Inc. (APEN) - 4 SEC Filings 03/07/2006
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 02/09/2006
Apollo Endosurgery, Inc. (APEN) - REGDEX SEC Filings 02/08/2006
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 02/06/2006
Apollo Endosurgery, Inc. (APEN) - 8-K/A - Current report SEC Filings 01/09/2006
Apollo Endosurgery, Inc. (APEN) - 8-K/A - Current report SEC Filings 12/21/2005
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 12/20/2005
Apollo Endosurgery, Inc. (APEN) - CORRESP SEC Filings 12/19/2005
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 12/15/2005
Apollo Endosurgery, Inc. (APEN) - SC 13G SEC Filings 12/12/2005
Apollo Endosurgery, Inc. (APEN) - 3 SEC Filings 12/12/2005
Apollo Endosurgery, Inc. (APEN) - UPLOAD SEC Filings 12/09/2005
Apollo Endosurgery, Inc. (APEN) - SC 14F1 SEC Filings 12/06/2005
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 12/06/2005
Apollo Endosurgery, Inc. (APEN) - 10QSB SEC Filings 10/28/2005
Apollo Endosurgery, Inc. (APEN) - 10QSB SEC Filings 08/22/2005
Apollo Endosurgery, Inc. (APEN) - 10QSB/A SEC Filings 08/18/2005
Apollo Endosurgery, Inc. (APEN) - NT 10-Q - Quarterly Report SEC Filings 08/12/2005
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 07/21/2005
Apollo Endosurgery, Inc. (APEN) - 10QSB SEC Filings 05/13/2005
Apollo Endosurgery, Inc. (APEN) - 10KSB SEC Filings 03/01/2005
Apollo Endosurgery, Inc. (APEN) - 10QSB SEC Filings 11/03/2004
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 10/26/2004
Apollo Endosurgery, Inc. (APEN) - 10QSB/A SEC Filings 10/26/2004
Apollo Endosurgery, Inc. (APEN) - 10KSB/A SEC Filings 10/26/2004
Apollo Endosurgery, Inc. (APEN) - 10QSB SEC Filings 08/17/2004
Apollo Endosurgery, Inc. (APEN) - NT 10-Q - Quarterly Report SEC Filings 08/16/2004
Apollo Endosurgery, Inc. (APEN) - 10QSB SEC Filings 05/20/2004
Apollo Endosurgery, Inc. (APEN) - NT 10-Q - Quarterly Report SEC Filings 05/14/2004
Apollo Endosurgery, Inc. (APEN) - 10KSB/A SEC Filings 03/25/2004
Apollo Endosurgery, Inc. (APEN) - 8-K - Current report SEC Filings 03/22/2004
Apollo Endosurgery, Inc. (APEN) - 10KSB SEC Filings 03/12/2004
Apollo Endosurgery, Inc. (APEN) - 10QSB SEC Filings 11/05/2003
Apollo Endosurgery, Inc. (APEN) - 10SB12G/A SEC Filings 07/17/2003
Apollo Endosurgery, Inc. (APEN) - 10SB12G SEC Filings 07/16/2003

Press Releases

StockPrice Release
Boston scientific announces results for fourth quarter and full year 2022 02/01/2023
Apollo endosurgery announces two important milestones in the advancement of endoscopic procedures for patients living with obesity 12/13/2022
Shareholder alert: rigrodsky law, p.a. is investigating apollo endosurgery, inc. buyout 12/06/2022
Shareholder investigation: halper sadeh llc investigates imgo, gray, apen, sal 12/06/2022
Shareholder alert: the m&a class action firm announces the investigation of apollo endosurgery, inc. - apen 12/05/2022
Apollo endosurgery investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of apollo endosurgery, inc. - apen 11/29/2022
Shareholder alert: weiss law investigates apollo endosurgery, inc. 11/29/2022
Shareholder alert: ademi llp investigates whether apollo endosurgery, inc. has obtained a fair price in its transaction with boston scientific 11/29/2022
Apollo endosurgery to be acquired by boston scientific 11/29/2022
Boston scientific announces agreement to acquire apollo endosurgery, inc. 11/29/2022
Apollo endosurgery, inc. reports record $19.6 million global revenue in third quarter 2022 11/01/2022
Apollo endosurgery to report third quarter results on november 1, 2022 10/18/2022
Endoscopic sleeve gastroplasty (esg) procedure featured as a "top 10" paper at the ifso 2022 world congress in miami 08/31/2022
Apollo endosurgery announces publication in the lancet of landmark study for the endoscopic sleeve gastroplasty procedure 07/29/2022
Apollo endosurgery to report second quarter results on august 2, 2022 07/21/2022
Fda grants de novo marketing authorization to apollo endosurgery for apollo esg(tm) and apollo revise(tm), new endoscopic systems for patients with obesity 07/13/2022
Sharon o'keefe joins apollo endosurgery board of directors 07/06/2022
Digestive disease week 2022 adds to the growing wave of clinical evidence supporting significant opportunity for apollo endosurgery products 05/31/2022
Apollo endosurgery products to take center stage at digestive disease week 05/18/2022
Apollo endosurgery to report first quarter results on may 3, 2022 04/13/2022
Apollo endosurgery appoints jeannette bankes to board of directors 04/04/2022
Apollo endosurgery to participate in the cowen healthcare conference 03/02/2022
Apollo endosurgery to report fourth quarter and full year results on february 22, 2022 02/10/2022
Apollo endosurgery appoints keely scamperle as vice president of reimbursement and market access 01/18/2022
Apollo endosurgery announces preliminary 2021 revenue results; reflecting 50% growth over 2020 01/10/2022
Apollo endosurgery announces new $100 million senior secured term loan facility from innovatus capital partners, llc 12/21/2021
Apollo endosurgery to present at four upcoming investor conferences 11/12/2021
Apollo endosurgery announces publication of a multicenter study of its x-tack(r)endoscopic helix tacking system 11/01/2021
Apollo endosurgery to report third quarter financial results on november 1, 2021 10/27/2021
Apollo endosurgery announces positive merit-trial outcomes 10/22/2021
Apollo endosurgery announces closing of public offering and exercise in full of option to purchase additional shares 10/15/2021
Apollo endosurgery announces pricing of $65 million public offering of common stock 10/12/2021
Apollo endosurgery announces commencement of public offering of common stock 10/12/2021
Apollo endosurgery announces preliminary third quarter 2021 financial results and provides business updates 10/07/2021
Apollo endosurgery to present at lake street's 5th annual best ideas growth conference 09/13/2021
Apollo endosurgery, inc. reports record endoscopy revenue in second quarter, raises full-year outlook conference call to discuss results today at 3:30 p.m. ct / 4:30 p.m. 08/03/2021
Apollo endosurgery to report second quarter financial results on august 3, 2021 07/27/2021
Apollo endosurgery appoints jeffrey g. black as chief financial officer 07/16/2021
Merit study investigators announce successful achievement of the study's primary efficacy & safety endpoints 06/14/2021
Apollo endosurgery to present at june investor conferences 06/01/2021
Apollo endosurgery's innovative overstitch(tm) endoscopic suturing system highlighted during digestive disease week 2021 05/24/2021
Apollo endosurgery to present at sidoti conference may 20 05/12/2021
Apollo endosurgery, inc. reports 29% increase in first quarter revenue 05/04/2021
Apollo endosurgery to report first quarter financial results on may 4, 2021 04/28/2021
Apollo endosurgery announces publication of pre-clinical results for x-tack(tm) endoscopic helix tacking system 04/21/2021
Apollo endosurgery announces inducement grant 03/19/2021
Apollo endosurgery announces ama assignment of category i cpt codes for use in intragastric balloon procedures 03/08/2021
Apollo endosurgery to present at hc wainwright global life sciences conference 03/03/2021
Apollo endosurgery to present at hc wainwright bioconnect conference 01/05/2021
Apollo endosurgery says discontinued employee furlough program 09/28/2020
Apollo endosurgery reports qtrly loss per share of $0.30 08/04/2020
Covid-19 impacts: intragastric balloons market will accelerate at a cagr of over 23% through 2020-2024\|increasing prevalence of obesity to boost growth\| technavio 08/04/2020
Surgical sutures market to cross $5 billion by 2027, despite covid-19 - researchandmarkets.com 07/08/2020
Insights on the worldwide bariatric surgery industry to 2028 - rise in government initiatives pertaining to obesity presents opportunities 07/01/2020
Global bariatric surgery market (2019 to 2028) - featuring apollo endosurgery, allergan & intuitive surgical among others - researchandmarkets.com 06/26/2020
Global obesity markets, clinical trials and companies 2016-2024 - researchandmarkets.com 05/11/2020
Apollo endosurgery - base salaries of employees whose annual base salary is at least $100,000 were capped at a pay rate equivalent to $100,000 04/20/2020
Apollo endosurgery reports quarterly loss per share of $0.34 03/26/2020
Apollo endosurgery, inc. presents at piper jaffray 31st annual healthcare conference, dec-05-2019 01:00 pm 11/24/2019
Apollo endosurgery, inc. has closed its shelf registration dated august 23, 2019 in the amount of $22.606485 million. 11/07/2019
Apollo endosurgery, inc. presents at the 10th annual craig-hallum alpha select conference, nov-12-2019 11/03/2019
Apollo endosurgery, inc. reports third quarter 2019 results 10/30/2019
Apollo endosurgery, inc. reports earnings results for the third quarter ended september 30, 2019 10/29/2019
Apollo endosurgery, inc. to report third quarter results on october 30, 2019 10/25/2019
Apollo endosurgery, inc., q3 2019 earnings call, oct 30, 2019 10/24/2019
Apollo endosurgery, inc. presents at microcap rodeo investor conference, oct-16-2019 01:30 pm 10/01/2019
Apollo endosurgery, inc. to report second quarter results on july 23, 2019 07/19/2019
Apollo endosurgery, inc. to report first quarter results on may 2, 2019 04/30/2019
Apollo endosurgery, inc. to report fourth quarter results on march 18, 2019 03/14/2019
Apollo endosurgery, inc. announces the sale of its surgical product line 12/18/2018
Apollo endosurgery, inc. to report third quarter results on november 8, 2018 11/06/2018
Apollo endosurgery, inc. to report second quarter results on august 8, 2018 08/06/2018
Apollo endosurgery, inc. to report first quarter results on may 3, 2018 04/26/2018
Apollo endosurgery, inc. to report fourth quarter and full year 2017 results on march 1, 2018 02/22/2018
Apollo endosurgery to report third quarter 2017 financial results on october 26, 2017 10/19/2017
Apollo endosurgery provides update and clarity to fda letter to health care providers related to potential risks of intragastric balloons 08/10/2017
Apollo endosurgery to report second quarter 2017 financial results on august 1, 2017 07/26/2017
Apollo endosurgery to report first quarter 2017 financial results on may 4, 2017 05/02/2017
Apollo endosurgery to report fourth quarter and full year 2016 financial results on march 8, 2017 03/06/2017

More Headlines

News
Apollo Endosurgery, Inc. (APEN) Q3 2022 Earnings Call Transcript Apollo Endosurgery, Inc. (NASDAQ:APEN ) Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Matt Kreps – Investor Relations Chas McKhann – Chief Executive Officer Jeff Black – Chief Financial Officer Conference Call Participants Mathew Blackman – Stifel Matt Hewitt – Craig-Hallum Capital Frank Takkinen – Lake Street Capital Josh Jennings – Cowen Simran Kaur – Piper Sandler Operator Good afternoon, ladies and gentlemen. And welcome to the Apollo Endosurgery Third Quarter 2022 Results Call. 11/01/2022
Apollo Endosurgery to Report Third Quarter Results on November 1, 2022 AUSTIN, TX / ACCESSWIRE / October 18, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release financial results for the third quarter ended September 30, 2022 on Tuesday, November 1, 2022, after market close. In conjunction with the release, Apollo will host a live webcast audio call with presentation slides at 3:30 p.m. 10/18/2022
Apollo Endosurgery, Inc. (APEN) CEO Chas McKhann on Q2 2022 Results - Earnings Call Transcript Apollo Endosurgery, Inc. (NASDAQ:APEN ) Q2 2022 Earnings Conference Call August 2, 2022 4:30 PM ET Company Participants Matt Kreps - Investor Relations Chas McKhann - Chief Executive Officer Jeff Black - Chief Financial Officer Conference Call Participants Chris Cooley - Stephens Simran Kaur - Piper Sandler Frank Takkinen - Lake Street Capital Matt Hewitt - Craig-Hallum Capital Operator Good afternoon, ladies and gentlemen and welcome to Apollo Endosurgery Second Quarter 2022 Results. At this time all participants have been placed on a listen-only mode and we will open the floor for your questions and comments after the presentation. 08/08/2022
Apollo Endosurgery: Collect Shares At A Discount Following Q2 Earnings Apollo Endosurgery came in with another strong quarter of top-line growth whilst growing gross margins on the same. The company saw substantial growth in each of its key segments, coupled with regulatory momentum in its Apollo ESG and REVISE series. 08/04/2022
Apollo Endosurgery to Report Second Quarter Results on August 2, 2022 AUSTIN, TX / ACCESSWIRE / July 21, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release financial results for the second quarter ended June 30, 2022 on Tuesday, August 2, 2022, after market close. In conjunction with the release, Apollo will host a live webcast audio call with presentation slides at 3:30 p.m. 07/21/2022
Hot Penny Stocks to Watch Right Now? 3 For Your July List Which penny stocks are you watching right now? The post Hot Penny Stocks to Watch Right Now? 07/13/2022
Apollo Endosurgery's New Obesity Endoscopic Systems Receive FDA Nod Apollo Endosurgery Inc (NASDAQ: APEN) announced the marketing authorization of the Apollo ESG, Apollo ESG Sx, Apollo REVISE, and Apollo REVISE Sx Systems through the FDA De Novo Classification process. The process is a premarket review pathway for low-to moderate-risk devices. 07/13/2022
This Analyst Thinks Apollo Endosurgery's Valuation 'Does Not Assign Full Value' - Read Why Stephens has reiterated an Overweight rating for Apollo Endosurgery Inc (NASDAQ: APEN) while increasing the price target from $8 to $9. "In our opinion, APEN's valuation does not assign full value to the promising ESS business or targeted opportunities for expanded. 05/04/2022
Apollo Endosurgery, Inc. (APEN) CEO Chas McKhann on Q1 2022 Results - Earnings Call Transcript Apollo Endosurgery, Inc. (NASDAQ:APEN ) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Matt Kreps - Investor Relations Chas McKhann - Chief Executive Officer Jeff Black - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Chris Cooley - Stephens Operator Good afternoon, ladies and gentlemen, and welcome to the Apollo Endosurgery First Quarter 2022 Results Conference Call. At this time, all participants have been placed on a listen-only mode, and we will open the floor for your questions and comments after the presentation. 05/03/2022
Apollo Endosurgery, Inc. (APEN) Reports Q1 Loss, Tops Revenue Estimates Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of 0% and 6.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock? 05/03/2022
Apollo Endosurgery to Report First Quarter Results on May 3, 2022 AUSTIN, TX / ACCESSWIRE / April 13, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (Nasdaq:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release financial results for the first quarter ended March 31, 2022 on Tuesday, May 3, 2022, after market close. In conjunction with the release, Apollo will host a live webcast audio call with presentation slides at 3:30 p.m. 04/13/2022
Apollo Endosurgery, Inc. (APEN) CEO Charles McKhann on Q4 2021 Results - Earnings Call Transcript Apollo Endosurgery, Inc. (APEN) CEO Charles McKhann on Q4 2021 Results - Earnings Call Transcript 02/22/2022
Apollo Endosurgery, Inc. (APEN) Reports Q4 Loss, Tops Revenue Estimates Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of -35% and 0.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? 02/22/2022
Apollo Endosurgery to Report Fourth Quarter and Full Year Results on February 22, 2022 AUSTIN, TX / ACCESSWIRE / February 10, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release financial results for the fourth quarter and full year ended December 31, 2021 on Tuesday, February 22, 2022, after market close. In conjunction with the release, Apollo will host a live webcast audio call with presentation slides at 3:30 p.m. 02/10/2022
Down 21.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Apollo Endosurgery, Inc. (APEN) Apollo Endosurgery, Inc. (APEN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. 01/14/2022
Apollo Endosurgery, Inc. (APEN) Moves 7% Higher: Will This Strength Last? Apollo Endosurgery, Inc. (APEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. 01/03/2022
Apollo Endosurgery to Present at Four Upcoming Investor Conferences AUSTIN, TX / ACCESSWIRE / November 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that management will participate in four upcoming investor conference events. Conferences Apollo Endosurgery management will participate include: Monday, November 15, 2021 Stifel 2021 Healthcare Conference (Virtual) Management will lead a group presentation at 4:00 pm Eastern Time on Monday, November 17. 11/12/2021
Apollo Endosurgery, Inc. (APEN) Moves to Buy: Rationale Behind the Upgrade Apollo Endosurgery, Inc. (APEN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). 11/04/2021
How Much Upside is Left in Apollo Endosurgery, Inc. (APEN)? Wall Street Analysts Think 35% The consensus price target hints at a 35.4% upside potential for Apollo Endosurgery, Inc. (APEN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. 11/04/2021
Apollo Endosurgery, Inc. (APEN) CEO Charles McKhann on Q3 2021 Results - Earnings Call Transcript Apollo Endosurgery, Inc. (APEN) CEO Charles McKhann on Q3 2021 Results - Earnings Call Transcript 11/01/2021
Recap: Apollo Endosurgery Q3 Earnings Apollo Endosurgery (NASDAQ:APEN) reported its Q3 earnings results on Monday, November 1, 2021 at 04:00 PM. Here's what investors need to know about the announcement. 11/01/2021
Apollo Endosurgery's Earnings Outlook Apollo Endosurgery (NASDAQ:APEN) is set to give its latest quarterly earnings report on Monday, 2021-11-01. Here's what investors need to know before the announcement. 10/29/2021
Apollo Endosurgery to Report Third Quarter Financial Results on November 1, 2021 AUSTIN, TX / ACCESSWIRE / October 27, 2021 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the third quarter ended September 30, 2021 on Monday, November 1, 2021 after the market closes. In conjunction with the release, Apollo will host a live webcast audio call with slides at 3:30 p.m. 10/27/2021
Apollo Endosurgery Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares AUSTIN, TX / ACCESSWIRE / October 15, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today the closing of its previously announced underwritten public offering. Apollo sold 9,660,000 shares of its common stock, including 1,260,000 shares sold pursuant to the underwriters' exercise in full of their option to purchase additional shares, at a public offering price of $7.75 per share for gross proceeds of approximately $75 million, before deducting underwriting discounts and commissions and offering expenses. 10/15/2021
Apollo Endosurgery Announces Pricing of $65 Million Public Offering of Common Stock AUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today the pricing of its previously announced underwritten public offering. Apollo is selling 8,400,000 shares of its common stock at a public offering price of $7.75 per share for gross proceeds of approximately $65 million, before deducting underwriting discounts and commissions and offering expenses. 10/12/2021
Apollo Endosurgery Announces Commencement of Public Offering of Common Stock AUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the common stock is being offered by Apollo. 10/12/2021
Apollo Endosurgery Announces Preliminary Third Quarter 2021 Financial Results and Provides Business Updates Revenue expected between $16.0 million and $16.4 million Third consecutive quarter of double-digit revenue growth; endoscopic suturing up over 30% Submitted a De Novo 510(k) Classification Request to FDA for Apollo ESG™ for weight loss and Apollo REVISE™ for prior bariatric surgery revisions Principal investigators expected to present primary efficacy and safety endpoints from MERIT study in late October AUSTIN, TX / ACCESSWIRE / October 7, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today preliminary unaudited financial results and corporate updates for the third quarter ended September 30, 2021, including anticipated revenue in the range of $16.0 million to $16.4 million and anticipated revenue growth in the range of 25% to 28% compared to third quarter 2020. Preliminary, Unaudited Third Quarter 2021 Financial Results Total revenue $16.0 million to $16.4 million Gross margin 54% to 56% Operating loss $(4.1) million to $(5.2) million Net loss $(6.1) million to $(7.3) million Non-GAAP adjusted EBITDA $(2.1) million to $(3.0) million "We continue to successfully deliver against the priorities that we committed to early this year: specifically, to energize our business and drive near-term growth while laying the foundation for additional large-scale opportunities," said Chas McKhann, president and CEO. 10/07/2021
Apollo Endosurgery to Present at Lake Street's 5th Annual Best Ideas Growth Conference AUSTIN, TX / ACCESSWIRE / September 13, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that its management team will participate in Lake Street's 5th Annual Best Ideas Growth Conference. September 14-15, 2021 Lake Street's 5th Annual Best Ideas Growth Conference Management teams from over 100 dynamic small-cap publicly traded companies will interact with over 300 institutional investors in a one-on-one conference format. 09/13/2021
APEN Stock Price Increases Over 7% Pre-Market: Why It Happened The stock price of Apollo Endosurgery, Inc. (Nasdaq:APEN) increased by over 7% pre-market. This is why it happened. 08/04/2021
Apollo Endosurgery, Inc. (APEN) CEO Chas McCallen on Q2 2021 Results - Earnings Call Transcript Apollo Endosurgery, Inc. (APEN) CEO Chas McCallen on Q2 2021 Results - Earnings Call Transcript 08/03/2021
Apollo Endosurgery, Inc. (APEN) Reports Q2 Loss, Tops Revenue Estimates Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of 35.29% and 17.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock? 08/03/2021
Apollo Endosurgery, Inc. Reports Record Endoscopy Revenue in Second Quarter, Raises Full-Year Outlook Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. AUSTIN, TX / ACCESSWIRE / August 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the second quarter ended June 30, 2021. Highlights Achieved total revenue of $16.6 million, an increase of 194% compared to the second quarter of 2020, and a new revenue record for the Company* Increased Endoscopic Suturing System (ESS) revenue 23% and Intragastric Balloon (IGB) revenue 16% on a sequential basis compared to the first quarter of 2021 Realized gross margin of 55% on favorable product mix Continued rollout of X-Tack™ with now more than 120 active sites, demonstrating excellent product performance, a short learning curve, and utility in a diverse range of upper and lower GI applications Reported that the Multi-Center ESG Randomized Interventional Trial (MERIT) study investigators announced successful achievement of the study's primary efficacy and safety endpoints Strengthened the Apollo leadership team with the additions of Kirk Ellis as Vice President of Sales, Steve Bosrock as Vice President of Marketing & Medical Education, and Jeffrey Black as Chief Financial Officer 2021 Outlook Based on results in the first half of 2021, the Company is increasing its guidance for the full year 2021 and now expects revenue between $61-$63 million, compared to its prior guidance of $55-$57 million. 08/03/2021
Will Apollo Endosurgery, Inc. (APEN) Report Negative Q2 Earnings? What You Should Know Apollo Endosurgery, Inc. (APEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 07/27/2021
Apollo Endosurgery to Report Second Quarter Financial Results on August 3, 2021 AUSTIN, TX / ACCESSWIRE / July 27, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the second quarter ended June 30, 2021 on Tuesday, August 3, 2021 after the market closes. In conjunction with the release, Apollo will host a conference call at 3:30 p.m. 07/27/2021
Apollo Endosurgery Appoints Jeffrey G. Black as Chief Financial Officer Veteran Executive Brings 30 Years of Financial and Operational Leadership Experience AUSTIN, TX / ACCESSWIRE / July 16, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced the hiring of Jeffrey G. Black as Chief Financial Officer. 07/16/2021
Apollo Endosurgery: New Management Bounce Makes Weight Loss Specialist A Buy Apollo Endosurgery is a medical device company developing innovative medical devices to advance gastrointestinal therapeutic endoscopy. The company's share price is +421% over the past 12 months and +130% since the arrival of a new CEO, Charles "Chas" McKhann in February. 06/28/2021
MERIT Study Investigators Announce Successful Achievement of the Study's Primary Efficacy & Safety Endpoints AUSTIN, TX / ACCESSWIRE / June 14, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced that investigators of the Multi-Center ESG Randomized Interventional (MERIT) study have reported based on a preliminary analysis the successful achievement of the study's primary endpoints. In a presentation at the 2021 Surgical Disruptive Technologies Summit meeting in Houston, Texas, Dr. Barham Abu Dayyeh, Professor of Medicine and Director of Advanced Endoscopy at the Mayo Clinic, commented, "I am very pleased to report that, in a preliminary analysis, the MERIT study comparing the Endoscopic Sleeve Gastroplasty (ESG) procedure to medically supervised moderate intensity lifestyle modification has achieved its primary endpoints for both efficacy and safety. 06/14/2021
Apollo Endosurgery to Present at June Investor Conferences AUSTIN, TX / ACCESSWWIRE / June 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announced that management will participate in two investor conference events during the month of June 2021. Conferences Apollo Endosurgery management will participate include: Wednesday, June 2, 2021 18th Annual Craig-Hallum Institutional Investor Conference Management will host one-on-one virtual meetings for institutional investors Wednesday, June 16 and Thursday, June 17, 2021 JMP Securities Life Sciences Conference Management will lead a group presentation at 3:30 pm Eastern Time on Thursday June 17 One-on-one virtual meetings available will be available for institutional investors For more information about scheduling a one-on-one meeting with management, please contact a Craig-Hallum or JMP Securities institutional sales representative or Matt Kreps, Investor Relations for Apollo Endosurgery, at mkreps@darrowir.com. 06/01/2021
Apollo Endosurgery's Innovative OverStitch(TM) Endoscopic Suturing System Highlighted During Digestive Disease Week 2021 AUSTIN, TX / ACCESSWIRE / May 24, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced highlights from Digestive Disease Week (DDW) 2021 which was held May 21-23. During the 3-day virtual event, there were more than 30 different presentations featuring the use of the OverStitch™ Endoscopic Suturing System in a variety of endoscopic procedures. 05/24/2021
Apollo Endosurgery to Present at Sidoti Conference May 20 AUSTIN, TX / ACCESSWIRE / May 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announced that it will participate in the Sidoti & Company Virtual Microcap Conference on May 20, 2021. Management will present an overview presentation on Thursday, May 20, at 10:00 am Eastern Standard Time. 05/12/2021
Apollo Endosurgery, Inc. (APEN) Reports Q1 Loss, Tops Revenue Estimates Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of 10.53% and 17.63%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock? 05/04/2021
Apollo Endosurgery, Inc. (APEN) CEO Charles McKhann on Q1 2021 Results - Earnings Call Transcript Apollo Endosurgery, Inc. (APEN) CEO Charles McKhann on Q1 2021 Results - Earnings Call Transcript 05/04/2021
Apollo Endosurgery, Inc. Reports 29% Increase in First Quarter Revenue Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. 05/04/2021
APEN Stock: From $5.59 To $5.81 (3.94% Increase) Pre-Market Explanation The stock price of Apollo Endosurgery Inc (NASDAQ: APEN) increased from $5.59 to $5.81 pre-market. This is why it happened. 05/03/2021
Apollo Endosurgery to Report First Quarter Financial Results on May 4, 2021 AUSTIN, TX / ACCESSWIRE / April 28, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the first quarter ended March 31, 2021 on Tuesday, May 4, 2021 after the market closes. In conjunction with the release, Apollo will host a conference call at 3:30 p.m. 04/28/2021
Will Apollo Endosurgery, Inc. (APEN) Report Negative Q1 Earnings? What You Should Know Apollo Endosurgery, Inc. (APEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 04/26/2021
Apollo Endosurgery Announces Publication of Pre-Clinical Results for X-Tack(TM) Endoscopic HeliX Tacking System Authors conclude, " Compared to TTS clip, X-Tack is superior for effecting large mucosal defect closure, including durable sealing of full-thickness perforation. " AUSTIN, TX / ACCESSWIRE / April 21, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the publication of supporting pre-clinical results for the X-Tack™ Endoscopic HeliX Tacking System. 04/21/2021
Apollo Endosurgery Announces Inducement Grant AUSTIN, TX / ACCESSWIRE / March 19, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the terms of equity awards granted to Chas McKhann in connection with his appointment as the company's CEO in March 2021. The company's board of directors granted Chas a stock option to purchase an aggregate of 848,733 shares of common stock, at a per share exercise price of $5.95, and a performance-based restricted stock unit award for 707,278 shares of common stock. 03/19/2021
Apollo Endosurgery announces AMA assignment of Category I CPT Codes for use in Intragastric Balloon Procedures AUSTIN, TX / ACCESSWIRE / March 8, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the assignment of Category I Current Procedural Terminology (CPT®) codes with short form descriptor esophagogastroduodenoscopy with deployment of gastric bariatric device (e.g., balloon) under endoscopic guidance. 03/08/2021
Apollo Endosurgery to Present at HC Wainwright Global Life Sciences Conference AUSTIN, TX / ACCESSWIRE / March 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it will participate in the H.C. Wainwright Global Life Sciences Conference taking place virtually March 9-10, 2021. 03/03/2021
APEN Stock Price Increases Over 55% Pre-Market: Why It Happened The stock price of Apollo Endosurgery Inc (NASDAQ: APEN) is trading at over 55% pre-market. This is why it happened. 03/01/2021
Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q4 2020 Results - Earnings Call Transcript Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q4 2020 Results - Earnings Call Transcript 02/27/2021
Apollo Endosurgery's Earnings: A Preview Apollo Endosurgery (NASDAQ:APEN) announces its next round of earnings this Thursday, February 25. Here is Benzinga's everything-that-matters guide for this Thursday's Q4 earnings announcement. 02/24/2021
Apollo Endosurgery to Present at HC Wainwright Bioconnect Conference AUSTIN, TX / ACCESSWIRE / January 5, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announced that it will participate in the H.C. Wainwright Bioconnect 2021 Conference taking place virtually January 11-14, 2021. 01/05/2021
Only 3% sugar cut out from food products in three years, PHE finds Public Health England study likely to accelerate calls for further measures such as sugar tax 10/07/2020
Revisiting Novo Nordisk (NYSE:NVO) With sales growing 8% and net profits growing 12% in the first half of 2020, Novo Nordisk could report solid numbers. 10/02/2020
Apollo Endosurgery (APEN) Presents At LD 500 Investor Virtual Conference - Slideshow The following slide deck was published by Apollo Endosurgery, Inc. in conjunction with this event.. 09/03/2020
LD Micro Announces Preliminary List of Presenters for the LD 500 LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. 08/05/2020
Apollo Endosurgery, Inc. Reports Second Quarter 2020 Results \| \| IT Business Net Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET AUSTIN, TX / ACCESSWIRE / August 4, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less 08/04/2020
Apollo Endosurgery, Inc. Reports Second Quarter 2020 Results Conference Call to Discuss Results Today at 3:30 p. 08/04/2020
COVID-19 Impacts: Intragastric Balloons Market will Accelerate at a CAGR of over 23% through 2020-2024\|Increasing Prevalence of Obesity to Boost Growth\| Technavio The Global Intragastric Balloons Market will grow by USD 144.87 mn during 2020-2024 08/04/2020
Apollo Endosurgery, Inc. to Report Second Quarter 2020 Results on August 4, 2020 AUSTIN, TX / ACCESSWIRE / July 30, 2020 / Apollo Endosurgery, Inc. 07/30/2020
Apollo Endosurgery Announces $25 Million Equity Financing, Solar Loan Amendment and Second Quarter Business Update AUSTIN, TX / ACCESSWIRE / July 20, 2020 / Apollo Endosurgery, Inc. 07/20/2020
A Look At The Intrinsic Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN) How far off is Apollo Endosurgery, Inc. (NASDAQ:APEN) from its intrinsic value? Using the most recent financial data... 07/13/2020
Surgical Sutures Market to Cross $5 Billion by 2027, Despite COVID-19 - ResearchAndMarkets.com The 07/08/2020
Apollo Endosurgery Announces 510k Submission for the X-Tack(TM) Endoscopic HeliX Tacking System for the Treatment of Gastrointestinal Defect Closures AUSTIN, TX / ACCESSWIRE / July 7, 2020 / Apollo Endosurgery, Inc. ("Apollo") (APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today the 510k submission of the X-Tack™ Endoscopic HeliX Tacking System to the U.S. Food and Drug Administration seeking clearance for the new, through-the-scope, suture-based device designed specifically for closing defects in the lower gastrointestinal tract with additional applications in the upper gastrointestinal tract. The X-Tack device enables physicians to place a series of individual HeliX Tacks into healthy tissue adjacent to a defect. 07/07/2020
APOLLO ENDOSURGERY, INC. : Changes in Registrant's Certifying Accountant (form 8-K) \| MarketScreener 07/01/2020
Insights on the Worldwide Bariatric Surgery Industry to 2028 - Rise in Government Initiatives Pertaining to Obesity Presents Opportunities Dublin, July 01, 2020 (GLOBE NEWSWIRE) -- The "Global Bariatric Surgery Market 2019-2028" report has been added to ResearchAndMarkets.com's ... 07/01/2020
Global Bariatric Surgery Market (2019 to 2028) - Featuring Apollo Endosurgery, Allergan & Intuitive Surgical Among Others - ResearchAndMarkets.com The 06/26/2020
Short Interest in Apollo Endosurgery Inc (NASDAQ:APEN) Declines By 10.8% Apollo Endosurgery Inc (NASDAQ:APEN) was the recipient of a large decline in short interest during the month of June. As of June 15th, there was short interest totalling 390,000 shares, a decline of 10.8% from the May 31st total of 437,400 shares. Currently, 3.2% of the company’s shares are sold short. Based on an average […] 06/20/2020
Is Apollo Endosurgery, Inc. (APEN) Going to Burn These Hedge Funds? In this article we will take a look at whether hedge funds think Apollo Endosurgery, Inc. (NASDAQ:APEN) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get tips […] 06/10/2020
Covid-19 lockdowns worsen childhood obesity globally: Study Lockdowns implemented across the world due to the COVID-19 pandemic have negatively impacted diet, sleep and physical activity among children with obesity. 06/04/2020
As the belly expands with age, the memory may shrink The part of the brain responsible for memory and learning normally continues to form new cells as people age, but if they are too heavy, it may shrink. 05/19/2020
Quantum Brakes to Learn About the Forces Within Molecules Physicists have measured the flight times of electrons emitted from a specific atom in a molecule upon excitation with laser light. This has enabled them to measure the influence of the molecule itself on the kinetics of emission. Photoemission – the release of electrons in response to excitation 05/16/2020
As Boris Johnson vows to lose weight - the 6 ways to do it safely OBESITY is known to double a patient’s chances of being hospitalised by coronavirus. And now Boris Johnson is planning to step up the nation’s fight against obesity as part of his plans… 05/15/2020
The truth about obesity and coronavirus - from 'crushed lungs' to organ failure WITH double the risk of being hospitalised, 37 per cent higher death rates and a lack of equipment once you’re in hospital, it’s fair to say the news for overweight Brits has been disma… 05/14/2020
Global Obesity Markets, Clinical Trials and Companies 2016-2024 - ResearchAndMarkets.com The 05/11/2020
Obese may be at risk of coronavirus because fat cells are virus target Researchers from Germany and the US explained fat cells secrete ACE-2 receptors - known as the 'gateway' into the cells of the body. 05/06/2020
Apollo Endosurgery, Inc. Reports First Quarter 2020 Results Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET AUSTIN, TX / ACCESSWIRE / May 4, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive ... 05/04/2020
Apollo Endosurgery, Inc. to Report First Quarter 2020 Results on May 4, 2020 AUSTIN, TX / ACCESSWIRE / April 30, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today ... 04/30/2020
Wells softens view on Edwards Lifesciences in premarket analyst action Adverum Biotechnologies (NASDAQ:ADVM) initiated with Buy rating and $17 (36% upside) price target at Goldman Sachs.Alector (NASDAQ:ALEC) initiated with Buy rating and $32 (21% upside) price target at 04/28/2020
Top Ranked Momentum Stocks to Buy for April 14th Top Ranked Momentum Stocks to Buy for April 14th 04/14/2020
Top Ranked Momentum Stocks to Buy for April 14th Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 14th 04/14/2020
Apollo Endosurgery Announces Completion of the US Post-Approval Study for the Orbera(R) Intragastric Balloon System AUSTIN, TX / ACCESSWIRE / April 13, 2020 / Apollo Endosurgery, Inc. ("Apollo") (APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures announced today that the US Food and Drug Administration (FDA) has completed the review of the final Post-Approval Study (PAS) Report for the Orbera Intragastric Balloon System and accepted that all post-approval study requirements have been fulfilled. The ORBERA Post Approval Study was a requirement following the US FDA's approval of ORBERA in August of 2015. 04/13/2020
Analysts Just Slashed Their Apollo Endosurgery, Inc. (NASDAQ:APEN) EPS Numbers By 15% One thing we could say about the analysts on Apollo Endosurgery, Inc. (NASDAQ:APEN) - they aren't optimistic, having... 03/31/2020
Is Apollo Endosurgery, Inc.'s (NASDAQ:APEN) CEO Paid Enough Relative To Peers? Todd Newton has been the CEO of Apollo Endosurgery, Inc. (NASDAQ:APEN) since 2014. This analysis aims first to... 03/28/2020
Analysts Have Lowered Expectations For Apollo Endosurgery, Inc. (NASDAQ:APEN) After Its Latest Results Last week, you might have seen that Apollo Endosurgery, Inc. (NASDAQ:APEN) released its annual result to the market... 03/28/2020
Apollo Endosurgery, Inc. Reports Fourth Quarter and Full Year 2019 Results AUSTIN, TX / ACCESSWIRE / March 26, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today ... 03/26/2020
Apollo Endosurgery, Inc. to Report Fourth Quarter and Full Year 2019 Results on March 26, 2020 AUSTIN, TX / ACCESSWIRE / March 24, 2020 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, ... 03/24/2020
Does Apollo Endosurgery, Inc. (NASDAQ:APEN) Have A High Beta? Anyone researching Apollo Endosurgery, Inc. (NASDAQ:APEN) might want to consider the historical volatility of the... 02/13/2020
Have Insiders Been Buying Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares? We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The... 12/30/2019
Apollo Endosurgery, Inc. (APEN): Hedge Funds In Wait-and-See Mode We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Hedge funds' top 3 stock picks returned 41.7% this year and beat […] 12/22/2019
5 ETFs & Stocks to Profit From One-Year High U.S. Inflation The annual U.S. inflation for the month of November beat expectations and put these ETFs and stocks in focus. 12/12/2019
Imagine Owning Apollo Endosurgery (NASDAQ:APEN) And Wondering If The 12% Share Price Slide Is Justified Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that... 11/12/2019
MicroCap Rodeo Investor Conference Lineup for October 15 and 16, 2019 AUSTIN, TX / ACCESSWIRE / October 15, 2019 / The MicroCap Rodeo's inaugural event is set for October 15, and 16 th , 2019 in Austin Texas at the Hilton downtown Austin. Focused on the best ideas concept, ... 10/15/2019
The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 23) Akero Therapeutics Inc (NASDAQ: AKRO ) Mirum Pharmaceuticals ... 07/24/2019
Apollo Endosurgery, Inc. to Host Earnings Call NEW YORK, NY / ACCESSWIRE / July 23, 2019 / Apollo Endosurgery, Inc. (NASDAQ: APEN ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July 23, 2019 at 4:30 ... 07/23/2019
What Investors Should Know About Apollo Endosurgery, Inc.'s (NASDAQ:APEN) Financial Strength Apollo Endosurgery, Inc. (NASDAQ:APEN) is a small-cap stock with a market capitalization of US$69m. While investors... 07/17/2019

Unlock

APEN Ratings Summary

APEN Quant Ranking